AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CASPIAN SUNRISE PLC

Transaction in Own Shares Dec 17, 2018

7547_rns_2018-12-17_31b63306-242e-411d-8b6d-79f6d06a7a3a.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7008K

Caspian Sunrise plc

17 December 2018

Caspian Sunrise PLC

("Caspian Sunrise" or the "Company")

Exercise of Options

The Company announces that following the notice of exercise of options over 1,200,000 shares exercisable at 4 pence each by Edmund Limerick (a Non-Executive Director of the Company) application has been made for these New Ordinary Shares to be admitted to trading on AIM. It is anticipated that trading in such shares will commence on or around 21th December 2018 ("Admission"), upon which Edmund Limerick and his wife will hold approximately 0.38% of the Company's total issued share capital.

Upon Admission, the total number of shares in issue will be 1,670,873,820 ordinary shares. This figure of 1,670,873,820 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

Caspian Sunrise PLC
Clive Carver

Executive Chairman
+7 727 375 0202
WH Ireland, Nominated Adviser & Broker
James Joyce

Jessica Cave

James Sinclair-Ford
+44 (0) 207 220 1666
Yellow Jersey PR

Tim Thompson
+44 (0) 203 735 8825

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

IOEEAFAXFDNPFFF

Talk to a Data Expert

Have a question? We'll get back to you promptly.